Drug Trial Radar · NCT02474420
Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients
Last checked: Nov 19, 2026Latest source record: Oct 26, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Jun 2015
Primary completion
Jun 2017
Study completion Jun 2018
Sponsor
- Lead sponsor
- Kevin H.M. Kuo, MD, MSc, FRCPCAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 17, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, open label, two arms superiority trial of a representative population of patients with a primary diagnosis of transfusion dependent thalassemia with evidence of moderate cardiac iron overload, defined as an average T2\* MRI parameter at the mid inter-ventricular septum between 10 and 20ms.
Conditions
- Beta-Thalassemia
- Iron Overload
Interventions
AmlodipineDrug
amlodipine titrated up to 10 mg daily or maximum tolerated dose, whichever comes first
DeferasiroxDrug
Deferasirox administered per standard of care by the treating physician
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in cardiac T2*Time frame: 12 months following randomization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Health Network
Toronto, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.